David Garrett, VP, Finance & Corporate Development at Dipexium Pharmaceuticals, Inc. (DPRX), bought 2,083 shares at $12.00 ($25K) on 2014-03-18, disclosed to the SEC on 2014-03-19.
Open-market purchase of $25k DPRX by VP, Finance & Corporate Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.